Our protocol goes far beyond the script, combining unlimited access to expert providers, personalized nutrition support, app-based tracking, and a connected patient community. In a retrospective analysis of 1,131 patients treated with the GLP-1 drug semaglutide, combined with individualized medical oversight, patients lost an average of 45.9 pounds (19.5% total body weight loss) at 52 weeks, with those extending to 68 weeks achieving an average total weight loss of 46.9 pounds (21.8%)
Now available on the market, JDC Burst 1 It is part of the segmented white strobe line of the German manufacturer GLP and its first hybrid team, which is a 10% brighter than that of its predecessor JDC1 , as well as more powerful in effects and color intensity
Some patients taking tirzepatide (Mounjaro, Zepbound) report experiencing taste changes, including metallic or altered taste sensations
Pregnancy Registry There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to DUPIXENT during pregnancy [see Use in Specific Populations (8.1)]
Semaglutide, as a single GLP-1 agonist, achieves meaningful but moderate weight loss at its maximum 2.4mg dose
